ATE358275T1 - Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analoga - Google Patents
Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analogaInfo
- Publication number
- ATE358275T1 ATE358275T1 AT02079785T AT02079785T ATE358275T1 AT E358275 T1 ATE358275 T1 AT E358275T1 AT 02079785 T AT02079785 T AT 02079785T AT 02079785 T AT02079785 T AT 02079785T AT E358275 T1 ATE358275 T1 AT E358275T1
- Authority
- AT
- Austria
- Prior art keywords
- metabolites
- fentanyl
- kit
- detecting
- quantifying
- Prior art date
Links
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical class C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 title abstract 4
- 230000002163 immunogen Effects 0.000 abstract 2
- 239000012876 carrier material Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204401 | 2001-11-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE358275T1 true ATE358275T1 (de) | 2007-04-15 |
Family
ID=8181257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02079785T ATE358275T1 (de) | 2001-11-16 | 2002-11-15 | Verfahren und kit zum nachweis, oder zum quantifizieren von, metaboliten von fentanyl und metaboliten von fentanyl analoga |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7109310B2 (de) |
| CN (1) | CN100402084C (de) |
| AT (1) | ATE358275T1 (de) |
| DE (1) | DE60219124T2 (de) |
| ES (1) | ES2284783T3 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040219685A1 (en) * | 2003-01-30 | 2004-11-04 | Applera Corporation | Methods and mixtures pertaining to analyte determination using electrophilic labeling reagents |
| US20060040406A1 (en) * | 2004-02-17 | 2006-02-23 | David Schneider | Narcotic analgesic tracking system |
| US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
| US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
| CA2734333A1 (en) * | 2008-09-16 | 2010-03-25 | Nektar Therapeutics | Pegylated opioids with low potential for abuse |
| ES2523896T3 (es) * | 2010-02-02 | 2014-12-02 | Randox Laboratories Ltd. | Inmunoensayo de zolpidem con ventana de detección extendida |
| CN102249986B (zh) * | 2011-02-28 | 2016-06-22 | 华东理工大学 | N-苯乙基-4-苯胺基哌啶的制备方法 |
| GB201313938D0 (en) * | 2013-08-05 | 2013-09-18 | Randox Lab Ltd | Immunoassay for phenethylamines of the 2C and DO sub-families |
| GB201409516D0 (en) | 2014-05-29 | 2014-07-16 | Randox Lab Ltd | Immunoassay for compounds of the NBOMe family |
| CN108884127A (zh) * | 2016-01-21 | 2018-11-23 | 斯克利普斯研究院 | 合成的阿片类疫苗 |
| US11660331B2 (en) | 2017-11-09 | 2023-05-30 | The Scripps Research Institute | Heroin vaccine |
| EP4049008A4 (de) * | 2019-10-21 | 2023-12-06 | Veriteque USA, Inc. | Verfahren zum nachweis von fentanylanaloga und kits dafür |
| US20220409722A1 (en) * | 2019-11-08 | 2022-12-29 | Regents Of The University Of Minnesota | Fentanyl hapten, fentanyl hapten-conjugates, and methods for making and using |
| US20230100186A1 (en) * | 2020-01-13 | 2023-03-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Fentanyl haptens for the preparation of a fentanyl vaccine |
| CN111257574B (zh) * | 2020-03-04 | 2024-01-16 | 中检国研(北京)科技有限公司 | 用于芬太尼类物质快速筛查的荧光免疫快检卡及制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0363041A1 (de) * | 1988-09-21 | 1990-04-11 | Ube Industries, Ltd. | Monoklonaler Antikörper gegen Morphin, Bereitung von monoklonalen Antikörpern, Testsatz und Verfahren zur Bestimmung von Morphin |
| EP0832106A2 (de) * | 1995-06-05 | 1998-04-01 | Cortech, Inc. | Verbindungen mit bradykinin antagonistischen aktivität und mu-opioid agonistischen aktivität |
| SE9803239D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
-
2002
- 2002-11-15 AT AT02079785T patent/ATE358275T1/de not_active IP Right Cessation
- 2002-11-15 US US10/295,700 patent/US7109310B2/en not_active Expired - Lifetime
- 2002-11-15 CN CNB021506655A patent/CN100402084C/zh not_active Expired - Fee Related
- 2002-11-15 DE DE60219124T patent/DE60219124T2/de not_active Expired - Lifetime
- 2002-11-15 ES ES02079785T patent/ES2284783T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7109310B2 (en) | 2006-09-19 |
| DE60219124T2 (de) | 2008-01-31 |
| US20030170728A1 (en) | 2003-09-11 |
| CN1428607A (zh) | 2003-07-09 |
| DE60219124D1 (de) | 2007-05-10 |
| CN100402084C (zh) | 2008-07-16 |
| ES2284783T3 (es) | 2007-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60219124D1 (de) | Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga | |
| ATE551352T1 (de) | Peptidakzeptorbindungsverfahren | |
| ATA8612001A (de) | Verfahren zum testen von software | |
| ATE256658T1 (de) | Funktionelle vitamin-d-derivate und verfahren zur bestimmung von 25-hydroxy- und 1alpha,25- dihydroxy-vitamin-d | |
| WO2000002917A3 (en) | Compounds and methods for modulating cadherin-mediated functions | |
| EP1216218A4 (de) | Verfahren zur anreicherung von kohlenwasserstoffen | |
| ATE465410T1 (de) | Vorrichtungen und verfahren zum nachweis von fruchtwasser in vaginalsekreten | |
| DE60126337D1 (de) | Verfahren zum screenen für gpr40-liganden | |
| DE58905253D1 (de) | Verfahren zum verstellen von reibungskupplungen oder -bremsen. | |
| DE60207016D1 (de) | Verfahren und Kit zur Quantifizierung von Beta-Laktam Penizillinen | |
| DE50104426D1 (de) | Verfahren zur vernetzung von polyacrylaten | |
| AR042652A1 (es) | Bromhidrato de escitalopram y un metodo para su preparacion | |
| FI884720A0 (fi) | Kompositioner foer anvaendning som kontrastmedel. | |
| DE50115254D1 (de) | Verfahren zum erkennen und/oder begrenzen von kurzndler | |
| DK0393304T3 (da) | Fremgangsmåde til foring af et underjordisk ledningsrør | |
| EP1305625A4 (de) | Verfahren zum immunnachweis von epitopen | |
| ATE539350T1 (de) | Verfahren zum nachweis oder zum bestimmen von hbv | |
| ATE370411T1 (de) | Verfahren zum screening | |
| DE50212790D1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| DE69022774D1 (de) | Verfahren zur Untergrundkorrektur zum Gebrauch in der Gaschromatographie. | |
| EP1728349A4 (de) | Verfahren zur verkürzung der durchlaufzeit eines ausführungselements durch einen kontrollpunkt | |
| DE50101211D1 (de) | Abklebewerkzeug und verfahren zum automatisierten, serienmässigen applizieren von klebeband | |
| MXPA01009272A (es) | Procedimiento de deformacion permanente de materias queratinicas que utiliza un agente absorbente organico. | |
| EP1312923A3 (de) | Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analogen | |
| DE50106697D1 (de) | Verfahren zum auffinden von objekten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |